<sup>18</sup>F-FDG Avidity in Lymphoma Readdressed: A Study of 766 PatientsMichal Weiler‐Sagie, Ora Israel, Rachel Bar‐Shalom et al.|Journal of Nuclear Medicine|2009Cited by 381
Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphomaZeev Blumenfeld, Eldad J. Dann, Jacob M. Rowe et al.|Fertility and Sterility|2007Cited by 179
Fertility after treatment for Hodgkin's diseaseZeev Blumenfeld, Jacob M. Rowe, Ron Epelbaum et al.|Annals of Oncology|2002Cited by 153
Risk-adapted BEACOPP regimen can reduce the cumulative dose of chemotherapy for standard and high-risk Hodgkin lymphoma with no impairment of outcomeEldad J. Dann, Ron Epelbaum, Rachel Bar‐Shalom et al.|Blood|2006Cited by 124
FDG avidity and PET/CT patterns in primary gastric lymphomaLea Radan, Ora Israel, Ron Epelbaum et al.|European Journal of Nuclear Medicine and Molecular Imaging|2008Cited by 82